HIGHLIGHTS
- who: Teng Zhu from the Department of Dermatology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China have published the Article: Meta-Analysis of the Efficacy and Safety of Interleukin-23-Targeted Drugs in the Treatment of Moderate-to-Severe Psoriasis, in the Journal: Contrast Media and Molecular Imaging of 28/06/2022
- what: In this study the purpose was to systematically evaluate the efficacy and safety of interleukin-23 (IL-23)-targeted drugs in the treatment of moderate-to-severe psoriasis and provide an evidence-based reference for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.